|
The GMDB scientific advisory board
The scientific advisory board (SAB) of GMDB provides advice, support and guidance to the GMDB team on the scientific direction, strategy, operations, and furtherance of its scientific mission. The SAB is also responsible for making the decisions about scientific access to the resource, notably those regarding the use GMDB data for machine learning and next-generation phenotyping. Members give their time and expertise to the project freely and discuss proposals that are pivotal in advancing the resource to deliver its strategy. Their broad skills and expertise ensure enhancements to GMDB meet the needs of the global research community, are scientifically relevant and meet the challenge of improving public health.Affilates
Koen Devriendt, MD
Center for Human Genetics, Uni Leuven, Belgium
Aleksandra Jezela-Stanek, MD
Department of Genetics and Clinical Immunology National Institute of Tuberculosis and Lung Diseases, Warsaw, Poland
Karen Gripp, MD
Division of Medical Genetics, A.I. du Pont Hospital for Children/Nemours, USA
Gholson J. Lyon, MD
NYS Institute for Basic Research in Developmental Disabilities (IBR), New York State, USA
Martin Mücke, MD
Department of General Medicine, University of Aachen, Germany
Christian Netzer, MD
Department of Human Genetics, University Hospital Cologne, Germany
Markus Nöthen, MD
Department of Human Genetics, University Hospital Bonn, Germany
Christian Schaaf, MD
Institute for Human Genetics, University Hospital Heidelberg, Germany
Alain Verloes, MD
Department of Clinical Genetics, Robert-Debré Hospital, Paris, France
Christoffer Nellåker, PhD
Nuffield Department of Women's & Reproductive Health, University of Oxford, United Kingdom
Benjamin Solomon, M.D.
Clinical Director National Human Genome Research Institute, Maryland, United States
Dr. Brain Chung, M.D.
Department of Paediatrics and Adolescent Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong